Introduction: Why Patient Recruitment Is the Costliest Bottleneck in Clinical Trials
Eighty percent of clinical trials fail to meet their enrollment timelines. Thirty percent of enrolled patients drop out before the trial concludes. And for every day a trial runs behind schedule, sponsors lose an estimated $600,000 to $8 million in unrealized revenue. Patient recruitment isn’t just a logistical problem — it’s the single largest cost and timeline driver in clinical development.
The traditional approach — site coordinators manually reviewing charts, running database queries, and making phone calls — simply can’t scale to meet the complexity of modern trial designs. Protocols now require narrow subgroups, specific biomarker profiles, and diverse populations across multiple geographies. AI is the only technology that can process the volume and complexity of data required to match the right patients to the right trials at the speed the industry needs.
In 2026, AI-powered recruitment has moved from pilot projects to production systems. Deep 6 AI (now part of Tempus) processes data from 30 million patients across thousands of research institutions. TriNetX’s federated network spans 300 million de-identified patient records. These aren’t experiments — they’re operational infrastructure that’s measurably compressing enrollment timelines.
This guide covers the AI tools purpose-built for patient recruitment and matching, how they integrate with your protocol design stack, and how to implement them.
The Recruitment Problem: What AI Is Actually Solving
Patient-trial matching at scale. The core challenge is connecting eligible patients with appropriate trials across a fragmented healthcare system. AI tools parse structured data (diagnoses, labs, medications) and unstructured data (clinical notes, radiology reports, pathology findings) to identify candidates who meet complex eligibility criteria — in minutes rather than weeks.
Prescreening accuracy. Manual chart review misses eligible patients and incorrectly flags ineligible ones. AI-powered NLP can process the full depth of a patient’s medical record, including free-text clinical notes that structured queries can’t access, achieving 93–96% accuracy in eligibility determination.
Diversity and representativeness. Regulatory agencies increasingly require trial populations that reflect the diversity of the intended treatment population. AI tools can identify eligible patients across underrepresented demographic groups and geographies, flagging diversity gaps before they become compliance issues.
Continuous matching. Traditional recruitment is a point-in-time activity. AI enables continuous patient matching — as new patients enter the health system and their records are updated, they’re automatically evaluated against active trial criteria and flagged for site teams.
Retention prediction. Some platforms now predict which enrolled patients are at risk of dropping out, enabling proactive interventions before the loss occurs.
The Recommended Patient Recruitment AI Stack
The recruitment stack has three layers: an EHR mining and matching engine that identifies eligible patients from medical records, a patient engagement platform that connects patients with trials through direct outreach, and a feasibility and analytics layer that optimizes site selection and enrollment forecasting.
Layer 1: EHR Mining and Patient-Trial Matching
Primary recommendation: Deep 6 AI (Tempus)
Deep 6 AI, acquired by Tempus in March 2025, is the leading AI platform for EHR-based patient recruitment. It uses NLP and machine learning to mine structured and unstructured electronic medical record data — including clinical notes, pathology reports, and radiology findings — to match patients to complex eligibility criteria in real time.
The platform’s reach is substantial: access to EMR data from 30 million patients, 30,000+ healthcare professionals, and thousands of active trials across leading research institutions, including six NCI-designated cancer centers. Deep 6 AI demonstrated a 170x speed improvement at Cleveland Clinic, identifying eligible trial candidates in minutes versus hours of manual review, with 96% accuracy.
Since the Tempus acquisition, the platform benefits from Tempus’s broader precision medicine infrastructure, including genomic data integration and real-world evidence capabilities.
Alternative: Mendel.ai — Specializes in oncology trial matching using clinical-genomic data. Strong in precision oncology where biomarker-driven eligibility criteria are complex and require deep genomic interpretation.
Layer 2: Patient Engagement and Direct Matching
Primary recommendation: Antidote (by Elligo Health Research)
Antidote takes the patient-facing approach to recruitment. Rather than mining institutional EHRs, Antidote connects patients directly to trials through digital matching technology. Patients register on the platform, provide health information, and receive notifications about relevant studies. Antidote partners with over 1,000 patient advocacy organizations and health communities to distribute trial information through trusted channels.
This approach is particularly valuable for disease areas with strong patient advocacy communities (oncology, rare diseases, neurology) and for reaching patients who don’t receive care at major academic medical centers. Antidote addresses the structural problem that most trials recruit from a narrow base of high-volume sites, missing the broader patient population.
Alternative: Trialbee — European-headquartered platform with strong EU data privacy compliance (GDPR). Uses AI to match patients from EHR, insurance claims, and real-world data sources. Good choice for global trials requiring European recruitment.
Layer 3: Feasibility, Site Selection, and Enrollment Analytics
Primary recommendation: TriNetX
TriNetX (covered in detail in the Protocol Design stack) extends naturally into recruitment. Its federated network of 300+ million patient records enables not just protocol pressure-testing but also site identification — showing you exactly which healthcare organizations are caring for your target patient population, with projections for how many eligible patients will present over the next 12 months.
For recruitment specifically, TriNetX’s AI-powered cohort analytics let you model enrollment scenarios: what happens to your recruitment timeline if you add a site in Brazil? If you relax one exclusion criterion? If a competing trial opens at three of your top-performing sites? This predictive layer turns recruitment from reactive to strategic.
Alternative: Phesi — Uses digital patient profiles and AI-driven simulations to forecast enrollment. Strong in predicting recruitment rates by geography and site, helping sponsors identify the optimal site footprint before activation.
Tool Comparison Matrix
| Feature | Deep 6 AI (Tempus) | Antidote | TriNetX | Trialbee | Mendel.ai |
|---|---|---|---|---|---|
| Primary function | EHR mining + matching | Patient engagement | Feasibility + analytics | AI patient matching | Oncology matching |
| Data source | 30M patient EHR records | Patient registrations + advocacy networks | 300M+ federated EHR | EHR + claims + RWD | Clinical-genomic data |
| Matching accuracy | 96% | N/A (patient-driven) | Cohort-level | High | High (biomarker-specific) |
| Unstructured data | Strong (NLP on notes, pathology, radiology) | N/A | Limited | Moderate | Strong (genomic reports) |
| Diversity tools | Yes (demographic analytics) | Yes (advocacy network reach) | Yes (population modeling) | Yes | Limited |
| Best for | Site-level recruitment acceleration | Direct-to-patient outreach | Strategic enrollment planning | EU/global trials | Precision oncology |
| Integration | Tempus ecosystem, EHR systems | Web platform, advocacy partners | Standalone SaaS | SaaS, API | EHR integration |
Implementation Guide: Building Your Patient Recruitment Stack
Step 1: Connect Recruitment to Protocol Design
If you’ve followed the Protocol Design stack, your eligibility criteria have already been pressure-tested against real-world patient populations using TriNetX. The validated criteria become the input for your recruitment tools — eliminating the gap between “designed criteria” and “operationalized criteria” that causes confusion at the site level.
Step 2: Deploy EHR Mining at Your Trial Sites
Start with Deep 6 AI (Tempus) at your highest-priority sites. The platform integrates with existing EHR systems to begin identifying eligible patients immediately. Focus on sites where enrollment has historically lagged — the AI matching will have the highest impact where manual processes are most strained.
Step 3: Layer Patient Engagement for Hard-to-Reach Populations
For trials in rare diseases, or where your sites don’t have sufficient patient volume, add Antidote’s patient engagement platform. This reaches patients who are actively seeking trials but aren’t connected to your site network. The combination of institutional EHR mining (Deep 6) plus direct patient outreach (Antidote) covers both supply-side and demand-side recruitment.
Step 4: Monitor and Optimize with Enrollment Analytics
Use TriNetX’s enrollment forecasting to track recruitment velocity against your timeline. When sites underperform, the analytics can diagnose why — is it a patient availability problem, a competing trial problem, or a site capacity problem? — and recommend corrective actions before the delay compounds.
Step 5: Automate Handoffs with Workflow Tools
Use Make.com to automate the operational handoffs:
- When a patient is identified as eligible, automatically notify the site coordinator via email or CTMS
- When enrollment milestones are hit (or missed), trigger alerts to the clinical operations team
- When a site’s enrollment rate drops below threshold, escalate to the site management lead
Compliance & Security: Patient Recruitment Tools
Healthcare AI tools handle sensitive clinical data. Before deploying any stack, your IT security and compliance teams should evaluate these considerations.
ROI and Evidence
- Deep 6 AI demonstrated 170x speed improvement in patient identification at Cleveland Clinic, with 96% accuracy
- TriNetX clients report 20%+ reduction in protocol amendments through criteria pressure-testing, which directly reduces recruitment restarts
- AI-powered recruitment can increase enrollment rates by up to 20% and cut development timelines by an average of 6 months per asset
- A 12-month reduction in clinical development is worth over $400 million in net present value for a single development program
- Antidote’s network of 1,000+ patient advocacy partnerships reaches populations that traditional site-based recruitment misses entirely
What’s Next in This Series
- Protocol Design and Simulation
- Patient Recruitment and Matching ← You are here
- Clinical Data Management — Next
- Safety Monitoring and Pharmacovigilance
- Medical Imaging AI
- Regulatory Submissions
- Clinical Documentation and Scribing
Return to the Complete AI Stack for Clinical Research | View all AI Healthcare Stacks
Published on EmergingAIHub.com | AI Workflow Intelligence for Healthcare Professionals
Last updated: March 2026
Key tools covered
Deep 6 AI, Antidote Match, BEKHealth, Carebox
Navigate the Clinical Research AI Stack Series
← Return to The Complete AI Stack for Clinical Research
Previous: Protocol Design AI Stack